270
Views
4
CrossRef citations to date
0
Altmetric
Review

Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Emanuele D’Amico, Aurora Zanghì & Francesco Patti. (2017) Can new chemical therapies improve the management of multiple sclerosis in children?. Expert Opinion on Pharmacotherapy 18:1, pages 45-55.
Read now
François Curtin, Virginie Vidal, Corinne Bernard, Arno Kromminga, Alois B. Lang & Hervé Porchet. (2016) Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study. mAbs 8:5, pages 854-860.
Read now

Articles from other publishers (2)

Antonio Scalfari & Paolo A Muraro. (2018) Monoclonal Antibody Therapy and Long-term Outcomes in Multiple Sclerosis – The Challenge of Treatment Optimisation. European Neurological Review 13:2, pages 78.
Crossref
Yasser El Miedany. (2015) MABS: targeted therapy tailored to the patient's need. British Journal of Nursing 24:Sup16a, pages S4-S13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.